Barclays analyst Ramsey El Assal maintained a Buy rating on Cognizant (CTSH – Research Report) yesterday and set a price target of $90.00. The ...

Barclays analyst Ramsey El-Assal lowered the firm’s price target on Cognizant (CTSH) to $90 from $103 and keeps an Overweight rating on the ...

The overall objective of this activity is to prevent, accurately diagnose, and optimally treat infectious diseases. Participants will also learn about new antibiotics and other therapeutic agents, ...